Tag: Neurodegenerative
Expert Panel Backs FDA Approval of New Alzheimer’s Drug
An expert panel recently gave its support for the FDA approval of a new drug for Alzheimer's disease called donanemab, manufactured by Eli Lilly. The panel, made up of independent advisors to the FDA,...